Benz Edward J. JR

CIK 00016911604 companiesNEEDHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001691160

Recent Transactions

30 trades

Award
Candel Therapeutics, Inc.$CADL
Stock Option (Right to Buy)
2025-06-17+14,240→ 14,240 total
Award
Candel Therapeutics, Inc.$CADL
Stock Option (Right to Buy)
2024-06-26+14,240→ 14,240 total
Disposition to Issuer
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2024-06-11−35,233→ 0 total
Disposition to Issuer
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2024-06-11−30,000→ 0 total
Disposition to Issuer
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2024-06-11−7,181→ 0 total
Disposition to Issuer
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2024-06-11−18,500→ 0 total
Disposition to Issuer
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2024-06-11−12,000→ 0 total
Award
Candel Therapeutics, Inc.$CADL
Stock Option (Right to Buy)
2023-06-28+14,240→ 14,240 total
Award
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2023-06-21+30,000→ 30,000 total
Disposition to Issuer
Renovacor, Inc.
Stock Option
2022-12-01−9,060→ 0 total
Disposition to Issuer
Renovacor, Inc.
Stock Option
2022-12-01−24,000→ 0 total
Award
Renovacor, Inc.
Common Stock
2022-12-01+3,586→ 3,586 total
Disposition to Issuer
Renovacor, Inc.
Stock Option
2022-12-01−12,000→ 0 total
Disposition to Issuer
Renovacor, Inc.
Common Stock
2022-12-01−3,586→ 0 total
Award
Candel Therapeutics, Inc.$CADL
Stock Option (Right to Buy)
2022-10-13+14,240→ 14,240 total
Award
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2022-06-23+18,500→ 18,500 total
Award
Renovacor, Inc.
Stock Option
2022-05-25+12,000→ 12,000 total
Award
Renovacor, Inc.
Option
2021-09-03+24,000→ 24,000 total
Award
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2021-06-23+12,000→ 12,000 total
Award
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-06-10+12,000→ 12,000 total
Award
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2019-06-11+12,000→ 12,000 total
Award
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2018-05-17+12,000→ 12,000 total
Exercise/Conversion
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2017-10-02+35,233→ 35,233 total
Exercise/Conversion
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2017-10-02+7,181→ 7,181 total
Exercise/Conversion
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2017-10-02−1,271→ 0 total
Exercise/Conversion
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2017-10-02−6,236→ 0 total
Award
Xenetic Biosciences, Inc.$XBIO
Stock Option
2016-12-20+6,250→ 25,000 total
Award
Xenetic Biosciences, Inc.$XBIO
Stock Option
2016-12-20+6,250→ 12,500 total
Award
Xenetic Biosciences, Inc.$XBIO
Stock Option
2016-12-20+6,250→ 18,750 total
Award
Xenetic Biosciences, Inc.$XBIO
Stock Option
2016-12-20+6,250→ 6,250 total

Companies

Recent Filings

Address

C/O CANDEL THERAPEUTICS, INC. 117 KENDRICK ST., SUITE 450

NEEDHAM, MA, 02494

View on SEC.gov